Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-29 @ 4:19 AM
Study NCT ID:
NCT00026312
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-24
First Post:
2001-11-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2012-01-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-19
Completion Date Type:
ESTIMATED
First Submit Date:
2001-11-09
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-09
Results First Submit QC Date:
None
Results First Post Date:
2017-03-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-24
Last Update Post Date Type:
ESTIMATED